CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Planned sale Chief Executive Officer sold 100 shares at $15.00 ($1,500)
- 4 Grant or award Chief Scientific Officer acquired 60,230 shares (grant or award)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 11,000 shares at $15.05 ($165,495)
- 4 Planned sale Chief Executive Officer sold 9,648 shares at $15.04 ($145,106)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 27,590 shares at an average $13.88 ($382,934)
- 4 Planned sale Director sold 2,410 shares at an average $13.77 ($33,192)
- 4 Grant or award Chief Executive Officer acquired 56,458 shares (grant or award)
- 4 Planned sale Director sold 10,000 shares at $11.27 ($112,691)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
- 4 Grant or award Director acquired 4,790 shares (grant or award)
Page 9 of 41 · 806 filings